Clinical Trials Logo

Clinical Trial Summary

This study is a multi-center study with a minimum of three CLIA-waived intended operator sites in the United States in which prospectively self-collected vaginal specimens obtained from subjects who are symptomatic or asymptomatic for CT, NG, or TV will be evaluated with the Click Sexual Health Test in a Clinical Laboratory Improvement Amendments (CLIA) waived setting. Subjects interested in participating in this study will be assessed for eligibility and asked to give informed consent and assent, if applicable, by the Investigational Review Board (IRB). Only those subjects who meet the inclusion and exclusion criteria may be enrolled in the study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04098900
Study type Observational
Source Visby Medical
Contact
Status Completed
Phase
Start date September 16, 2019
Completion date December 3, 2019

See also
  Status Clinical Trial Phase
Completed NCT03613649 - Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects Phase 1
Completed NCT02961751 - Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae N/A
Completed NCT03073538 - Screening of Gonococcal and Chlamydial Infections in the Third Trimester
Completed NCT04870138 - Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial) Phase 1
Terminated NCT01291264 - Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM] Phase 4
Completed NCT03852316 - Clinical Study of a Diagnostic Device for NG, TV and CT in Women N/A
Recruiting NCT04350138 - Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection Phase 2
Completed NCT01849653 - Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing N/A
Completed NCT03840811 - Experimental Human Infection With Neisseria Gonorrhoeae Phase 1